Skip to main content

News & Insights

An expert holding a microphone gives a talk about in vitro diagnostic clinical trials to an interested audience.
 
All News & Insights

Our industry is constantly evolving, from in vitro diagnostic (IVD) advances and New regulatory requirements to Emerging Technologies and clinical trial best practices. Get an expert perspective from Beaufort.

CASE STUDY
Project Overview A leading diagnostics company partnered with Beaufort to conduct a prospective, multicenter, observational diagnostic study across the United States and Canada to support the ... Read more
BLOG
Authored by: Christine Scheve SVP, Chief Revenue Officer Walk the floor at The MedTech Conference and the innovation is impossible to miss: AI-enabled imaging, nanoparticle therapies, ... Read more
BLOG
Insights from the AMDM IVD Focus Meeting highlight opportunities to reassess regulatory pathways, leverage existing evidence and refine CDx development strategies. Authored by: Christine Scheve SVP, ... Read more
ANNOUNCEMENT
Beaufort, a MedTech contract research organization (CRO), today announced a series of executive appointments as the company enters its next stage of growth, strengthening leadership across ... Read more
ANNOUNCEMENT
Beaufort welcomes Christine Scheve as Senior Vice President, Chief Revenue Officer. With hands-on experience spanning research, product development, and regulatory strategy, Christine translates complex client needs ... Read more
ANNOUNCEMENT
Beaufort announces the retirement of Schuyler Ritter, Co-Founder, EVP and Chief Commercial Officer, after 22 years of leadership. Schuyler co-founded Beaufort with a vision to build ... Read more
ARTICLE
Success depends on more than conducting an effective IVD clinical trial program or even securing a favorable regulatory determination. It requires building an evidence-generation strategy that ... Read more
ARTICLE
Introduction Since application of Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) in May 2022, CDx manufacturers, medicine sponsors, notified bodies, national competent authorities ... Read more
ARTICLE
Considerations for Sponsors Navigating a Shifting Landscape Authored by: Bill Trembley Senior Vice President, Chief Technology Officer AI is Already Inside the Building Every clinical research ... Read more
ARTICLE
Authored By: Beaufort Regulatory Team On 27 November 2025, the European Commission published Commission Decision (EU) 2025/2371, formally confirming that the first four modules of EUDAMED—Actor ... Read more
ARTICLE
EU and U.S. Regulatory Considerations for Post-Market Advertising and Promotion of IVDs Authorized in vitro diagnostic medical device (IVD) claims must be supported by a defined ... Read more
BLOG
Authored by: Beaufort Regulatory Team The AMDM IVD Focus Fall Meeting brought together regulators, industry leaders, and diagnostic professionals for two days of focused discussion and ... Read more
 
Event

On Aug 20, Beaufort is presenting “Clinical Trials with CDx—Navigating the Complexity of the IVDR” at the … Read more

Article

As medical devices, including IVDs, increasingly incorporate sophisticated software components, understanding and complying with FDA guidance on software documentation … Read more

Article

Navigating FDA’s Final Rule on LDTs. 6 strategies to help you meet FDA requirements and maintain market access … Read more

Blog

Beaufort celebrates 20 years of growth and innovation — and helping clients advance human health through the rapid development and commercialization … Read more

Article

Key considerations to ensure regulatory readiness and achieving contemporaneous drug and CDx authorizations. … Read more

Event

Visit Beaufort in Booth # 4739 at the ADLM 2024 Annual Meeting in Chicago (July 30 – Aug 1). Set a meeting with our experts.… Read more

Event

Beaufort will be presenting “Exploring the CDx Landscape” at the 17th Annual IVD Clinical and Regulatory Affair … Read more

Blog

FDA Letter to Industry Calls on Device Sponsors to Independently Verify Third-Party Data … Read more